Koios Beverage (CSE:KBEV, OTC:SNOVF) (the “Company” or “Koios”), is pleased to release a corporate overview of the Company’s activities in its first six months of operations, since retail sales began in May, 2018.

Koios Founder and CEO Chris Miller says the Company has enjoyed a rapid pace of growth since launching its first line of functional nootropic beverages early this year.


“Our focus in this first year has been to develop and refine our line of functional beverages, but also to build out our distribution network as quickly as possible,” Miller said. “I think we have met or exceeded the benchmarks we set for the Company on both those goals, and in addition we have zeroed in on building out our e-commerce, direct to consumer and distribution platforms as efficiently and quickly as possible.”

On the production side, Koios signed a critical agreement expanding its production capacity by partnering with Rocky Mountain Soda, a well known producer of high-end organic beverages. The partnership has allowed Koios to test small runs of new products while at the same time lowering costs for increased production.

In a similar manner, Koios signed a cooperation agreement with cannabis beverage producer Keef Brands, which accelerated development of cannabis beverages under its wholly owned subsidiary Cannavated Beverage Co.

“As a result of this flexibility Koios has been able to accelerate product development,” said Miller. “Through our wholly owned subsidiary Cannavated, we formulated the first nootropic beverage infused with CBD (cannabidiol), and we are preparing to launch beverages containing a mix of CBD and THC for the rapidly growing cannabis beverage market.

Koios is best known for the benefits of its proprietary nootropic stack of mind enhancing ingredients that improve mental acuity, memory and alertness. Miller says the agreements with like-minded companies has allowed Koios to produce other product lines quickly. These include nootropic powders that provide a higher dosage of ingredients.

The Company also announced in early September that Koios Beverage Corp. will begin production of a new line of functional beverages under the brand Fit Soda, beginning in the first quarter of 2019. The Fit Soda line of beverages are as much about taste as they are about the benefits of health supplements. “The idea was to create a beverage that gives you all the taste you expect from a quality soda product, but with none of the guilt,” Miller says. “It’s a ‘soda with benefits’.”

One of the company’s main goals over the first two quarters of operations was to increase distribution. On this front Koios has developed relationships with several major retailers and distribution networks representing thousands of outlets, including Europa Sports, Sportlife Distribution, KeHe, Wishing-U-Well, Alfalfa’s Market, Western Functional Beverages, and FC Food Co-Op.

“Increasing distribution is key to any company’s success, and we continue to push hard to get our products on more shelves,” said Miller. “Even now, we are working to sign up more major distributors to carry our brand across the US and Canada.”

About the Company’s Business

The Company, through its wholly-owned subsidiary Koios, Inc., is an emerging functional beverage company which has a large and growing distribution network of retail locations across the United States in which to sell its products. Koios has relationships with some of the largest and most reputable distributors in the United States, including Europa Sports, SportLife Distribution, KeHE, and Wishing-U-Well.  Together these distributors represent more than 80,000 brick-and-mortar locations across the United States – from sports nutrition stores to large natural grocery chains including Whole Foods and Sunflower markets.  Through its partnership with Wishing-U-Well, Koios also enjoys a large presence online, including being an Amazon choice product.

Koios uses a proprietary blend of nootropics and natural organic compounds to enhance human productivity without using harmful chemicals or stimulants.  Koios products can enhance focus, concentration, mental capacity, memory retention, cognitive function, alertness, brain capacity and create all day mental clarity.  Its ingredients are specifically designed to target brain function by increasing blood flow, oxygen levels and neural connections in the brain.

Koios recently launched a wholly owned subsidiary, Cannavated Beverages Co. to develop a line of cannabis infused, brain-healthy drinks for the legal marijuana market.

Koios is one of the only drinks in the world to infuse its products with MCT oil.  MCT oil is derived from coconuts and has been shown to help the body burn fat more effectively, create lasting energy from a natural food source, produce ketones in the brain, allowing for greater brain function and clarity, support healthy hormone production and improve immunity. For more information, please visit our website: https://www.mentaltitan.com/

On behalf of the Board of Directors of the Company.

KOIOS BEVERAGE CORP.

“Chris Miller”
Chris Miller, CEO and Director
403-889-9128

Forward-Looking Statements

This news release contains forward-looking statements. All statements, other than statements of historical fact that address activities, events or developments that the Company believes, expects or anticipates will or may occur in the future are forward-looking statements. Forward-looking statements in this news release include statements regarding the timing for resumption of trading for the Company’s stock. The forward-looking statements reflect management’s current expectations based on information currently available and are subject to a number of risks and uncertainties that may cause outcomes to differ materially from those discussed in the forward-looking statements. Although the Company believes that the assumptions inherent in the forward-looking statements are reasonable, forward-looking statements are not guarantees of future performance and, accordingly, undue reliance should not be put on such statements due to their inherent uncertainty. Factors that could cause actual results or events to differ materially from current expectations include general market conditions and other factors beyond the control of the Company. The Company expressly disclaims any intention or obligation to update or revise any forward-looking statements whether as a result of new information, future events or otherwise, except as required by applicable law.
Koios has not conducted any scientific studies on the effects of Koios’s products which have been evaluated by Health Canada or the U.S. Food and Drug Administration. As each individual is different, the benefits, if any, of taking Koios’s products will vary from person to person. No claims or guarantees can be made as to the effects of Koios’s products on an individual’s health and wellbeing.

For further information: Paula Arab, Media and Investor Relations Strategist, paula.arab@koiosbeveragecorp.com, 403-889-9128

Source: www.newswire.ca

American cannabis sales hit US$17.5 billion in 2020, a research group’s new study shows.

Meanwhile, a Canadian cannabis producer began offering CBD beverages in the US, another move that shows how interested Canadians are in the overall US cannabis market at the moment.

Keep reading... Show less

An Emerging Markets Sponsored Commentary

Some pretty important news out of health and wellness; beverage and natural products company BevCanna Enterprises Inc. (CSE:BEV, Q:BVNNF, FSE:7BC) this week. For those of you following the Company with us, stay tuned.

Keep reading... Show less

As investors continue to prioritize cannabis opportunities in the US, market watchers expect mergers and acquisitions (M&A) to play a role in the future for Canadian companies.

A consolidation trend has been expected in the Canadian cannabis space for some time now based on the size of the market compared to the number of operations in the country.

Keep reading... Show less

The product will include polyphenols known to have significant health benefits.

BioHarvest Sciences Inc. (CSE: BHSC) (“BioHarvest” or the “Company”) has reached an important milestone in its development program of additional Nutraceuticals. The olive-based Nutraceutical product scheduled for market availability in the second half of 2022 will contain the following unique matrix of polyphenols: hydroxytyrosol, trosol, and verbascoside. These compounds are the major polyphenols in naturally grown olives and are responsible for the high antioxidant activity of olives and olive oil. Importantly, the BioHarvest olive-based Nutraceutical product will provide all the benefits of olives and olive oil with a low calorie count per serving.

Keep reading... Show less

Cresco Labs (CSE:CL) (OTCQX:CRLBF) (“Cresco” or the “Company”), one of the largest vertically integrated multistate cannabis operators in the United States, announced today that it will report financial results for the fourth quarter and full year ended December 31 st , 2020 on Thursday March 25 th , 2021 before the market opens.

The Company will host a conference call and webcast to discuss its financial results and provide investors with key business highlights on Thursday March 25 th , 2021 at 8:30am Eastern Time (7:30am Central Time).

Keep reading... Show less